Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and...

Related Keywords

United States ,American ,Stephen Kilmer ,Anixa Biosciences ,Axel Ullrich ,Mike Catelani ,Jennifer Davis ,Brian Leyland Jones ,H Michael Shepard ,Dennis Slamon ,Robert Weinberg ,Vincent Tuohy ,Facebook ,Harvard Medical School ,Innovative Breast Cancer Research ,Linkedin ,Anixa Biosciences Inc ,Department Of Inflammation ,Youtube ,Warren Alpert Foundation Prize ,National Cancer Institute ,Winship Cancer Centre ,Cleveland Clinic Lerner Research Institute ,Mcgill University ,Health Science At Emory University ,Moffitt Cancer Center ,Antonio Breast Cancer Symposium ,Call Details ,Triple Negative Breast Cancer ,Michael Shepard ,Key Opinion Leader ,Alpert Award ,Lasker Debakey Award ,Developmental Therapeutics ,Founding Chair ,Mcgill University Comprehensive Cancer Center ,Minda De Gunzberg Chair ,Associate Vice President ,Health Science ,Emory University ,Iris November Distinguished Chair ,Cleveland Clinic ,Lerner Research ,Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,